Together, our results demonstrate that the concentration of a prion protein is a key factor for prion propagation. We propose a model to explain how prion protein overexpression can produce a detrimental effect on prion propagation and why Ure2p Sp might be more sensitive to such effects than Ure2p Sc .
INTRODUCTION
Prions were originally defined as a unique class of infectious agents composed solely of protein. In mammals, prions cause fatal neurodegenerative diseases, such as CreutzfeldtJacob disease in human, sheep scrapie, and bovine spongiform encephalopathy (Prusiner et al., 1982; Aguzzi et al., 2007; Collinge and Clarke, 2007) . All these diseases are linked to abnormal self-propagating conformations of a cellular protein termed PrP. The yeast Saccharomyces cerevisiae possesses at least four different prion proteins (Sup35, Ure2p, Rnq1p, and Swi1p) (Wickner, 1994; Derkatch et al., 2001; Du et al., 2008) . Yeast prions are denoted within brackets and by capital letters to specify that they correspond to cytoplasmically transmitted inheritable elements that are dominant in genetic crosses. The yeast prion proteins exhibit clear mechanistic similarities with PrP. In particular, mammalian and yeast prions have the ability to polymerize into amyloid aggregates (for reviews, see Baskakov, 2007; Wickner et al., 2007) . Interestingly, biochemical pathways controlling prion formation and/or maintenance seem conserved from yeast to humans because antiprion drugs, isolated in yeast-based screening assays, inhibit mammalian prion propagation and vice versa (Bach et al., 2003) .
Numerous results highlight the clear connection between the yeast prion phenotype and the aggregation of the protein involved in this process (Patino et al., 1996; Edskes et al., 1999; Paushkin et al., 1997; Zhou et al., 2001) . Reconstitution of in vivo infectivity from amyloid fibers formed in vitro from purified protein has definitively proven the proteinonly hypothesis for prion formation and established indubitably the link between amyloid fibers and the prion form propagated in cells (Tanaka et al., 2004 (Tanaka et al., , 2006 Brachmann et al., 2005; King and Diaz-Avalos, 2004; Patel and Liebman, 2007) . Other proteins form amyloids in an autocatalytic manner, but only prion proteins are infectious. The exact nature of the self-propagating species still remains unclear. Indeed, the Ure2p aggregates isolated from [URE3] cells differ from amyloid filaments formed in vitro (Ripaud et al., 2004) . Genetics studies on yeast prions have revealed the existence of cellular factors required for prion aggregation and propagation. Notably, the de novo appearance and subsequent propagation of yeast prions is highly dependent on the expression levels of a number of molecular chaperones (reviewed in Perrett and Jones, 2008) . Biochemical analysis of [PSI ϩ ] propagating yeast extracts showed that Ssa1/ Ssa2 chaperones were the major components interacting with infectious Sup35 aggregates (Bagriantsev et al., 2008) .
To ensure an efficient transmission of prion in actively dividing cultures, prion aggregates must be continually subdivided to yield additional replication templates known as prion seeds or propagons. The disaggregating Hsp104 chaperone has the most critical and universal role in yeast prion maintenance, and it is essential to remodel existing prion complexes to generate or maintain propagons (Chernoff et al., 1995; Satpute-Krishnan et al., 2007) . Then, propagons are partitioned to daughter cells, where they continue to direct the conversion of neosynthesized protein to the prion form and ensure inheritance of the associated phenotype.
The Ure2p prion protein controls catabolism of nitrogen sources. In the presence of a good nitrogen source, Ure2p blocks the uptake of poor nitrogen sources by sequestering the transcription factor Gln3p in the cytoplasm (Beck and Hall, 1999; Cox et al., 2000) . One of these genes activated by Gln3p is the allantoate permease gene, DAL5 (Turoscy and Cooper, 1987) . Because of the structural similarity between allantoate and ureidosuccinate (USA), an essential intermediate of uracil biosynthesis, Dal5p can take up USA (Aigle and Lacroute, 1975) . Prion conversion of Ure2p leads to its loss of function and consequently, enables the uptake of ureidosuccinate (USA) and permits growth on an ad hoc selective medium. Ure2p is a two-domain protein. The asparagine and glutamine rich N-terminal domain of Ure2p, termed prion-forming domain, is unstructured in the soluble form of the protein and is crucial for prion properties, whereas its C-terminal domain is compactly folded and sufficient to perform the cellular function in nitrogen regulation (Masison and Wickner, 1995) . Although the catalytic function of Ure2p in nitrogen regulation was found to be conserved among all analyzed Saccharomyces species, controversial results were obtained concerning the conservation of prion-forming properties (Edskes and Wickner, 2002; Baudin-Baillieu et al., 2003) . In particular, we did not detect [URE3] prion capacity with Ure2p from Saccharomyces paradoxus (Ure2p Sp ), whereas H. Edskes and coworkers reported that this protein could form a prion. The conflicting studies differed in two experimental aspects. One difference was the expression level of Ure2p in yeast cells, the other was the existence of a silent mutation in the construct used by Edskes et al. that could lead to an artifactual translational read-through of URE2 (Talarek et al., 2005) .
De novo prion generation is a stochastic process. Transient overproduction of the prion protein increases the frequency of prion formation (Wickner, 1994; Derkatch et al., 1996) . This property was proposed by R. Wickner as one of the indicators that a heritable non-Mendelian state is due to a prion-based determinant and is now regarded as a fundamental property of such systems (for review, see Wickner et al., 2006) . The rationale behind this argument is simply that a higher concentration of the protein enhances the probability of prion nucleation. However, high amounts of prion protein can also interfere with propagation (Edskes et al., 1999; Ripaud et al., 2003; Allen et al., 2005 
MATERIALS AND METHODS

Nomenclature
To avoid confusion, we used S. cerevisiae (Sc) or Saccharomyces paradoxus (Sp) in subscript to specify the gene origin. For prion nomenclature, [ure3-0] is used to name the soluble or nonprion status of Ure2p and [URE3] is used to name the prion status.
Plasmids and DNA Manipulations
All plasmids used in this study are listed in Table 1 . The full-length URE2 open reading frames (ORFs) of the S. cerevisiae and S. paradoxus are placed under control of the inducible GAL10-CYC1 promoter and are carried either by the monocopy plasmid (with an ARS-CEN origin of replication) pG1URE2 Sc and pG1URE2 Sp or by the multicopy plasmid (with a 2 origin of replication) pG2URE2 Sc and pG2URE2 Sp . The multicopy plasmids pG2URE2 Sc -green fluorescent protein (GFP) and pG2URE2 Sp -GFP were originally described by Ripaud et al. (2003) and Immel et al. (2007) , respectively. pFL39-URE2 Sp , containing the URE2 Sp ORF flanked by promoter and terminator sequence of URE2 Sc , was constructed as follows. The URE2 Sp ORF was amplified using oligonucleotide 37 (5Ј-GTCATATTGTTTTAAGCTGCAAAT-TAAGTTGTACACCAAATGATGAATAACAACGGTAAC-3Ј), which introduces a sequence homologous to the URE2 Sc promoter at the 5Ј of the gene and oligonucleotide 41 (5Ј-TTTCCTCCTTCTTCTTTCTTTCTTGTTTTTA-AAGCAGCCTTTATTCACCACGCAATGCCTT-3Ј), which introduces a sequence homologous to the URE2 Sc terminator at the 3Ј of the gene. This fragment was cloned into the pFL39URE2 Sc , carrying a genomic fragment of URE2 Sc , by using the gap repair method (Orr-Weaver and Szostak, 1983) .
Strains, Media, and Genetic Methods
All strains used in this study are disrupted for the URA2 gene. S. cerevisiae strain CC30 (MAT␣, 112, 15, ⌬ura2::HIS3) was used as the [ure3-0] parent and is termed URE2 Sc in this publication (Fernandez-Bellot et al., 2000) . The strain AB34, termed here URE2 Sc [URE3] , is isogenic to URE2 Sc and carries the [URE3] strain originally described by Aigle and Lacroute (1975) URE2 Sp ORF into the URE2 locus of S. cerevisiae, the AF36 strain (MATa, 112, 15 (MAT␣, 112, 15 . URE2 Sc and URE2 Sp ORFs were discriminated by NotI restriction of the polymerase chain reaction (PCR) fragment generated using oligonucleotides 214 5Ј-GATGAATAACAACG-GCAACC-3Ј and 220 5Ј-CCGTAAACTCTTCTAACCTC-3Ј). Growth and handling of S. cerevisiae involved standard techniques. Standard yeast media have been described previously (Baudin-Baillieu et al., 2003) . Induction of protein expression under control of GAL10 promoter was performed by growth in medium containing either 4% raffinose or 2% galactose ϩ 4% raffinose as the carbon source. The [URE3]/USA ϩ phenotype of ura2 strains was tested on a minimal medium containing ammonium as the nitrogen source and supplemented with appropriate amino acids and 15 mg/ml USA. Strains were cured of the [URE3] prion by growth on YPDA medium supplemented with 3 mM guanidine hydrochloride (GuHCl).
Quantifying the [URE3] Prion Formation
To evaluate spontaneous prion apparition, serial 10-fold dilution of cells were plated on medium supplemented with USA or with uracil. Colonies were counted after incubation for 3 d at 30°C for plates containing uracil and after incubation for 5 d for plates supplemented with USA. Frequency of USA ϩ colony formation was calculated as the ratio of the number of colonies on USA to number of colonies on uracil. To determine the induction rate of transient overexpression of Ure2p on prion formation, cells were grown for 3 d in medium containing 2% galactose and 2% raffinose dropout medium lacking leucine. Frequency of USA ϩ colony formation was determined as described above on SD medium lacking leucine supplemented with USA or with uracil. All frequencies indicated in this work were determined as the average of at least five independent experiments. To rule out a potential masking of the [URE3] phenotype on dextrose medium supplemented with USA, because of the presence of residual Ure2p after induction on galactose medium, cells were grown on dextrose medium supplemented with uracil for 2 d before selection of USA ϩ colonies. This supplementary step allows growth of the cells and dilution of any remaining Ure2p. By this approach, the obtained results led to the same conclusions as when selection of USA ϩ colonies was performed immediately after the transient overexpression of Ure2p.
[URE3] Curing by Guanidine Hydrochloride and Counting Propagons
After overnight growth on YPD (except for URE2 Sc pG1URE2 Sc which were grown on 2% YPGalactose), cells were grown in YPD with 3 mM GuHCl. Cultures were maintained in exponential growth (between 0.1 and 1 OD 600 ) by successive dilutions into liquid YPD medium with 3 mM GuHCl. At regular time points, aliquots of cultures were withdrawn and plated on SD medium supplemented either with uracil or with USA. The frequency of USA ϩ colonies was determined as described above. The number of propagons was derived from the kinetics of GuHCl-induced prion curing according to Cox et al. (2003) . The data are plotted as the percentage of [URE3] cells as a function of generations of growth in YPD ϩ GuHCl. The number of propagons can be calculated from the value of 2 g , where g is the number of generations elapsed at the time point when 36.8% of cells had lost the prion, assuming that the propagon number halves at each generation.
Protein Extraction, Sedimentation Analysis, and Western Blotting
Total yeast extracts (glass beads disruption with Fast-prep24 [MP Biomedicals, Irvine CA] in TNT buffer: 25 mM Tris-HCl, pH 7.4, 100 mM NaCl, and 0.2% Triton X), sedimentation analyses, Western blotting and treatment with antibodies were performed as described previously (Ripaud et al., 2003; Immel et al., 2007) . Before heating at 95°C, urea was added to a 8 M final concentration to the loading buffer of all extracts from yeast cells propagating the prion. To measure the amount of Ure2p in various strains, yeast extracts were prepared by alkaline lysis. Briefly, 5 OD 600 units of yeast cells in exponential phase were permeabilized with 1 ml of 0.185 M NaOH, 0.2% mercaptoethanol for 10 min on ice. Trichloroacetic acid was added to a final concentration of 5%, and the samples were incubated for an additional 10 min on ice. Precipitates were collected by centrifugation at 14,000 ϫ g for 5 min. The pellets were neutralized and dissolved in 30 l of dissociation buffer (4% SDS, 0.1 M Tris-HCl, pH 6.8, 4 mM EDTA, 20% glycerol, 2% 2-mercaptoethanol, and 0.02% bromphenol blue) and 15 l of 1 M Tris base, and heated at 95°C for 5 min. One to 5 l was loaded onto a 12% SDS-polyacrylamide gel. Western blotting and immunoblotting with Ure2p and Ade13p antibodies were performed as described previously (Ripaud et al., 2003) . Signal intensity was quantified using the Amount One software (Bio-Rad, Hercules, CA).
Microscopy Techniques
URE2 Sc and URE2 Sp cells propagating [URE3] were transformed with the pG2URE2 Sc -GFP and pG2URE2 Sp -GFP plasmids, respectively. Cells were grown on YNB medium (0.67%) supplemented with 2% dextrose, appropriate amino acids, and 15 mg/l USA to 0.8 -1 OD 600 . Cells were washed and suspended in YNB medium (0.67%) supplemented with 4% raffinose or 2% galactose. Cells were then pelleted at different times and resuspended in DABCO maintaining solution (218 mM diazabicyclo 2-2-2 octane [SigmaAldrich], 25%, vol/vol phosphate-buffered saline, and 75%, vol/vol glycerol). Cells were observed and photographed with a DMRB microscope (Leica, Wetzlar, Germany) with a 100ϫ HCX PL fluotar objective.
Preparation of Yeast Extract and Test of [URE3] Infectivity
Yeast extract were prepared as described in the supplemental experimental procedures of Brachmann et al. (2005) . URE2Sc pG2URE2 Sc -GFP cells propagating [URE3] were grown as described above for microscopy analyzes. Approximately 150 OD of cells were resuspended in 250 l of ST buffer (1.2 M sorbitol and 10 mM Tris-HCl, pH 7.5) and disrupted with 0.5-mm glass beads in ice for 20 s using the Fast-prep24 (MP Biomedicals). Whole cells extract were briefly clarified at 500 ϫ g for 30 s.
Yeast extract were transformed into [ure3-0] cells as described in the supplemental experimental procedures of Shorter and Lindquist (2006) . Briefly, spheroplasts were recovered from URE2 Sc yeast cells after digestion with lyticase (L-5263; Sigma-Aldrich). Spheroplasts were resuspended in STC buffer (1.2 M sorbitol, 10 mM CaCl 2 , and 10 mM Tris-HCl, pH 7.5) and mixed with yeast extracts (15 l of whole cells extracts for 100 l of spheroplasts suspension), a LEU2 plasmid (pRS426; 0.02 mg/ml), and salmon sperm DNA (0.1 mg/ml). Fusion was induced by addition of 9 volumes of polyethylene glycol (PEG) buffer (20%, wt/vol PEG8000, 10 mM CaCl 2 , and 10 mM TrisHCl, pH 7.5). Then, 330 Leu ϩ transformants were spotted onto SD supplemented with USA. To ensure USA ϩ colonies corresponded to [URE3], test for curing of the USA ϩ phenotype were carried out by streaking cells for single colonies onto YPD containing 3 mM guanidine HCl and then checked for the loss of USA ϩ phenotype. The numbers of [URE3] colonies relative to total transformants was then determined. A negative control without extracts was performed, which only rarely gave rise to spontaneous [URE3] clones. To make sure that potential surviving cells from yeast extract did not yield false positives in transformation experiments, we platted the cells extracts (incubated without pRS426 by using the transformation procedure described above) and have verified that it did not yield Leu ϩ colonies.
RESULTS
Ure2p Sp Can Adopt a Prion Form When Expressed at Physiological Level
To determine whether Ure2p Sp can sustain [URE3] propagation when it is expressed at physiological level, we constructed an S. cerevisiae strain in which the URE2 Sp ORF was integrated at the URE2 locus under control of the endogenous URE2 Sc promoter (this strain is termed URE2 Sp ). The expression of Ure2p Sp was similar to that of Ure2p Sc , as determined by Western blotting ( Figure 1A ). As reported previously, Ure2p Sp can perform the nitrogen catabolism repression function of Ure2p Sc , and as a consequence, the URE2 Sp strain shows a USA Ϫ phenotype ( Figure 1B ) (Baudin-Baillieu et al., 2003) .
We wondered whether the Ure2p Sp protein could be converted into a prion form in the presence of preexisting [URE3] . For that purpose, we crossed the URE2 Sp (Edskes et al., 1999; Ripaud et al., 2004 (Derkatch et al., 2000; Zhou et al., 2001; Bradley and Liebman, 2004) . Frequency of USA ϩ formation was determined for a URE2 Sp strain. Spontaneous USA ϩ formation occurred at about the same rate as in URE2 Sc cells (ϳ2 in 10 5 cells) ( Figure 1D ). The majority of the USA ϩ cells were cured in presence of 3 mM GuHCl. As expected, when reselected on USA-containing medium, USA ϩ clones occurred in such cured clones at a similar frequency as in the original cells (data not shown). We conclude from this set of experiments that when expressed at physiological level, Ure2p Sp can spontaneously form [URE3] and stably propagate it.
High Overexpression of Ure2p Sp Abolishes Its Prion Properties
In apparent contradiction with the results reported in the previous section, we had reported previously that Ure2p Sp is not able to convert into the [URE3] prion form (BaudinBaillieu et al., 2003; Talarek et al., 2005) . Because the only difference between the present experiment and these previous studies was the use of different promoters, we wondered whether the capacity to support prion propagation could be dependent on Ure2p cellular concentration. So, we expressed different amounts of Ure2p Sc and Ure2p Sp in URE2 Sc and URE2 Sp [URE3] cells, respectively. We used monocopy or multicopy plasmids carrying the URE2 Sc or URE2 Sp ORF under control of the GAL10 promoter. After growth in galactose medium, the amount of Ure2p was quantified by Western blotting experiments ( Figure 3A ). Monocopy and multicopy plasmids led to approximately a 50-and a 500-fold overexpression, respectively, compared with Ure2p expressed from URE2 at the chromosomal locus. It was noted that the amount of Ure2p Sp is slightly higher than Ure2p Sc regardless of the promoter. S. cerevisiae and S. paradoxus Ure2p share the exact same sequence in their globular domains, and the differences are restricted to the prion-forming domain (Supplemental Figure S1 ) (Edskes and Wickner, 2002; Baudin-Baillieu et al., 2003) . Because this domain is essential to stabilize the catalytic domain of Ure2p , the sequence differences in the prion-forming domain sequence between two orthologues might result in distinct stability of Ure2p.
We then tested the ability of the yeast cells to propagate [URE3] by testing their capacity to grow on galactose medium containing USA. As a control, we confirmed that the transformation per se did not impair the prion phenotype ( Figure 3B, SDϩUSA) . As published previously, a strong overexpression of Ure2p Sc is compatible with growth on USA medium, whereas a very strong overexpression of Ure2p Sp is not ( Figure 3B, SGϩUSA) Figure 3B , SGϩUSA). The observation that Ure2p Sp overexpression led to severe inhibition of prion propagation contrasts with the fact that transient overexpression of Ure2p increases the frequency of prion formation (Wickner, 1994; Baudin-Baillieu et al., 2003) . So, we have also determined the effect of massive Ure2p Sp transient overexpression on [URE3] formation. We transiently expressed various amounts of Ure2p Sc or Ure2p Sp . Prion apparition was assayed as formation of USA ϩ colonies on a dextrose medium ( Figure 3C ). As reported previously, an increase of Ure2p Sc promoted the appearance of [URE3] at a higher frequency (Wickner, 1994 (Fernandez-Bellot et al., 2002) . The expression system is based on high copy number plasmids, the coding sequence of Ure2p Sc -GFP or Ure2p Sp -GFP being under the control of the inducible galactose promoter. Different patterns of aggregation, which were never detected in [ure3-0] cells, were observed. We grouped these patterns in four classes (Figure 4) . We distinguish cells with small numerous foci quoted as the small aggregates class. We also observed cells with one large dot among smaller foci (medium aggregates class). The two other classes of aggregation are branching structures in which elongations are short (large aggregates) or long (very large aggregates). Formation of these distinct aggregates was not due to the overexpression of the Ure2p Sc -GFP construct itself because the same results were obtained when a low expression level of the Ure2p Sc -GFP fusion was used to decorate the Ure2p aggregates (Supplemental Figure S2) .
We quantified the proportion of each of the four defined classes at different times after the induction of the expression of the fluorescent protein in a cell population ( Figure 5A ). The switch from dextrose to galactose medium was realized during late exponential phase. Because of the metabolic transition in this condition, less than one generation occurs during the first 24 h. We thus consider that we are dealing with a nondividing cell population. For each observation, at least two classes coexisted, but their ratio changed during the kinetics. Immediately after the induction of Ure2p Sc -GFP or Ure2p Sp -GFP, most cells belong to the small aggregates class. Few hours later, the proportion of this class has a clear tendency to decrease, and more cells with medium aggre- 
High Overexpression of Ure2p Accelerates the Aggregation Dynamics of Ure2p
We have demonstrated that the [URE3] prion properties depend on the amount of Ure2p. We therefore studied the aggregation kinetics of Ure2p Sc and Ure2p Sp at two distinct cellular concentrations of Ure2p Sc -GFP and Ure2p Sp -GFP. To this purpose, we have induced the expression either with raffinose or raffinose ϩ galactose as the carbon source. Raffinose, contrary to dextrose, does not repress the GAL10 promoter, allowing a weak expression of the protein. In this condition, the proportion of cells containing small aggregates decreased slowly with both orthologues ( Figure 5B) . Indeed, ϳ40% of the cells still correspond to the small aggregates class 24 h after the onset of induction. In contrast, when fluorescent proteins were overexpressed by inducing with galactose, this cell population had totally disappeared 9 h after the induction of overexpression. Moreover, in overexpression conditions, we observed emergence of cells with large aggregates as soon as 6 h after the onset of induction, whereas they were never formed when Ure2p Sc -GFP or Ure2p Sp -GFP was expressed at low levels. These results show that the concentration of cellular Ure2p influences its aggregation dynamics in [URE3] cells.
We also observed that, in galactose ϩ raffinose medium, there is a significant difference in the aggregation dynamic of Ure2p Sc -GFP and Ure2p Sp -GFP ( Figure 5A ). The proportion of cells exhibiting small aggregates decreases more rapidly with Ure2p Sp -GFP. In fact, 6 h after galactose induction, 58% of cells expressing Ure2p Sc -GFP contained small aggregates, whereas the proportion of this population was only 12% with Ure2p Sp -GFP. Moreover, Ure2p Sp -GFP formed large aggregates more efficiently than Ure2p Sc -GFP because after 24 h, 92% of the cells expressing Ure2p Sp -GFP contained these particular aggregates compared with 35% for cells expressing Ure2p Sc -GFP. In fact, at all time points, aggregates were larger in Ure2p Sp -GFP than in Ure2p Sc -GFP-expressing cells. These results clearly demonstrated that the aggregation dynamics rely not only on the cellular concentration of the prion protein but also on its primary sequence.
The Aggregation Dynamics of Ure2p Defines the Number of [URE3] Propagons
We wondered whether the differences in aggregation dynamics of Ure2p in [URE3] cells (URE2 Sc , URE2 Sc overexpressing Ure2p and URE2 Sp strains) could be correlated with variations in the number of [URE3] propagons per cell. We have estimated the number of [URE3] propagons by the method described by Eaglestone et al. (2000) . This analysis is based on chemical inactivation of Hsp104 by low concentrations of GuHCl that inhibits prion replication and thus leads to rapid prion loss in dividing cells by progressive dilution of the propagons (Eaglestone et al., 2000; Ferreira et al., 2001) .
[URE3] strains (URE2 Sc , URE2 Sc overexpressing Ure2p and URE2 Sp strains) were transferred during log phase into YPD medium supplemented with 3 mM GuHCl; at regular time points, cells density was determined and cultures were spread on plates to determine the percentage of [URE3] loss. In the strain overexpressing Ure2p Sc , the overexpression was stopped when cells were transferred into YPD supplemented with 3 mM GuHCl.
As expected, the kinetics of [URE3] curing displayed two phases; there was a lag phase during which no curing occurred followed by a linear increase in the number of cured cells over time (Figure 6 ) (Eaglestone et al., 2000; Ripaud et al., 2003) . The curing profile for the [URE3] URE2 Sc strain was much slower than that observed in either the [URE3] URE2 Sc strain overexpressing Ure2p Sc or the [URE3] URE2 Sp strain. For the two latter strains, the elimination of [URE3] was so fast that the lag phase was not always apparent in the four performed independent curing kinetics ( Figure 6 ). The number of propagons in [URE3] cells can be inferred from these kinetics of elimination. From the method developed by B. Cox (Cox et al., 2003) , we estimate the apparent number of propagons to be 52 for [URE3] URE2 Sc strain. This number is much larger than that found for either [URE3] URE2 Sp or [URE3] URE2 Sc overexpressing Ure2p (15 and 10 propagons, respectively). These results show that the number of propagons is influenced by the primary sequence of the Ure2p prion-forming domain, and remarkably, that an increase of cellular concentration of Ure2p decreases the number of propagons. In other terms, we have correlated a variation of aggregation dynamic of Ure2p with variations in the numbers of [URE3] propagons.
Infectivity of Ure2p Aggregates and Their Ability to Propagate as a Prion Can Be Dissociated
In a previous study, we showed that the formation of large aggregates of Ure2p correlates with [URE3] elimination (Ripaud et al., 2003) . We confirm that in these experimental conditions, when only the large and very large aggregates were observed, the majority of cells lost the [URE3] prion. Indeed, when the overexpression of Ure2p Sc -GFP in [URE3] cells was stopped after 24 h of induction, only 5 ϫ 10 Ϫ4 cells still maintained the USA ϩ phenotype on glucose medium (data not shown). This strong and fast prion elimination led us to propose that curing of [URE3] occurred by inactivation of propagons through the massive aggregation of Ure2p ( Ripaud et al., 2003) . This inactivation could result from the formation of structurally distinct off-pathway nonprion Ure2p aggregates due to overexpression. Alternatively, inactivation could simply be because of the sequestration of the propagons in the mother cell through their assembly into bigger aggregates. In the latter hypothesis, the Ure2p large aggregates should be structurally related to the bona fide prion aggregates and should therefore conserve their ability to induce [URE3] Figure 7A ) and that are thus structurally related with the propagating prion aggregates.
The above-mentioned finding prompted us to investigate whether the cells with large aggregates of Ure2p are able to generate new transmissible aggregates. To that purpose, the progeny of cells with the large Ure2p-GFP aggregates were analyzed for their fluorescent aggregates content. After one generation, the proportion of cells with large aggregate clearly decreased, suggesting that large aggregates are nontransmissible (Supplemental Table S1 ). In accordance with the observed fast prion elimination, in microcolonies, daughter cells of mothers containing large aggregates Ure2p-GFP consistently contained no aggregates ( Figure 7B ). In a control experiment, the daughter cells of mothers propagating [URE3] prion exhibited the same aggregation pattern (small aggregates, visualized by the expression of a low level of Ure2p Sc -GFP from the pH327 plasmid) (Supplemental Figure S3) .
Together, these results suggest that the infectivity of Ure2p aggregates and their ability to propagate as a prion can be dissociated.
DISCUSSION
In this study, we showed that Ure2p of S. paradoxus possesses the capacity to switch into a [URE3] prion conformation. Our analyses demonstrated that the expression level of Ure2p Sp strongly modulates this capacity. The ability to induce the prion form and/or to propagate this self-inactivation is observed only when Ure2p Sp was not expressed at high level. In contrast, Ure2p Sc and Ure2p of S. uvarum orthologue exhibited these prion properties regardless of the amount of Ure2p that is expressed (Baudin-Baillieu et al., 2003) . Ure2p Sp prion propagation is possible in S. cerevisiae (Edskes and Wickner, 2002; this study) . In a previous study, however, we failed to isolated [URE3] clones when Ure2p Sp was expressed in its genuine cellular context, namely, in S. paradoxus (Talarek et al., 2005) . Expression level of Ure2p Sp in S. paradoxus was similar to the ones allowing prion propagation in S. cerevisiae. Why [URE3] propagation from Ure2p Sp could not be detected in S. paradoxus is unclear at present. It might be that Ure2p Sp prion propagation cannot occur in that host or else that prion formation occurs at a very low frequency.
The native yeast prion proteins change from the functional form to the prion form more frequently if the parent genes are overexpressed. As a rule, it is widely accepted that "the more you express, the more prion you get." The observed frequency of prion formation after a transitory overexpression of Ure2p Sc or Ure2p Sp from a monocopy plasmid is 100-fold higher than the rate of spontaneous acquisition of the prion at normal expression level. When the transient overexpression is performed from a multicopy plasmid, the cellular level of Ure2p is increased ϳ10-fold compared with Ure2p level produced from a monocopy plasmid. If the induction of [URE3] apparition was strictly proportional to the amount of Ure2p, the prion formation should also increase in the same extent. Surprisingly, strong overexpression of Ure2p Sc led to the same induction rate as mild overexpression. The effect was even more dramatic with Ure2p Sp because increasing its protein concentration (from mild to strong overexpression) decreases (rather than increased) the frequency with which [URE3] arises. So, increasing the pool of Ure2p does not continually augment the occurrence of the event that initiates prion formation.
Yeast prion determinants are related to amyloid polymerization. In vitro, purified Ure2p spontaneously forms amyloid fibers, and the introduction of such fibers into [ure3-0] yeast cells leads to the [URE3] prion phenotype (Brachmann et al., 2005; Immel et al., 2007) . But not all amyloid-forming proteins are prions. Tanaka et al. (2006) developed an elegant model, experimentally validated, that accounts for the difference between a noninfectious and a prion (infectious) amyloid. They proposed that the infectious nature of an amyloid is defined by two fundamental parameters: the rate of polymer elongation and its susceptibility to shearing. An amyloid aggregate can be propagated as a prion in a population of dividing cells only if, in combination, these parameters surpass a threshold to allow sustained propagation. Possible explanations for the impairment of prion properties when Ure2p is strongly overexpressed could therefore be related to a change either in the rate of amyloid growth or in the brittleness of the aggregates. The fragmentation frequency of an amyloid fiber is defined by the intrinsic physical properties of this particular amyloid conformation. It is unlikely that an increased level of Ure2p results in a change of conformational structure of its amyloid fibers. Conversely, in vitro, the speed of Ure2p fiber growth is linearly proportional to the concentration of soluble Ure2p (Fay et al., 2003) . Similarly, our in vivo analysis highlighted that the aggregation dynamics of Ure2p is faster when cellular concentration of Ure2p increases. We showed that the Ure2p aggregates isolated from cells which no longer propagate [URE3] still retain their ability to induce [URE3] once artificially introduced in wild-type [ure3-0] cells. This result suggests that the large aggregates are structurally related to the amyloid [URE3] prion aggregates and do not correspond to a distinct off-pathway aggregate. The high levels of Ure2p increase the speed of polymerization of fibers. Consequently, it is possible that above a threshold Ure2p amount, the formed aggregates are not self-propagating because their size increase and coalescence is too rapid. In this model, rapidly growing and coalescing Ure2p aggregates would fail to be segregated properly to daughter cells during cell divisions, as shown by our microscopy observations ( Figure 7B ). In agreement with this model, is the fact that increasing the cellular concentration of Ure2p results in a reduction of [URE3] propagon number ( Figure 6 ).
Here, we showed that the aggregation pathway of the two Ure2p orthologues share the same intermediates states. However, a major difference lies in the aggregation dynamics that is faster for Ure2p Sp than for Ure2p Sc . Consequently, we observed many more cells containing very large aggregates when Ure2p Sp is overexpressed. Similarly, our in vitro analyses showed that Ure2p Sp exhibits a higher propensity to aggregate than Ure2p Sc (Immel et al., 2007) . We have also demonstrated that Ure2p Sp is able to assemble in an infectious amyloid and that this one was significantly more resistant than the Ure2p Sc amyloid to mechanical shearing (Immel et al., 2007) . Interestingly, our propagon counting assay indicated that the apparent number of propagons per cell in the [URE3] URE2 Sp strain was much smaller than that found in [URE3] URE2 Sc (Figure 7) . Therefore, we can speculate that Ure2p Sp would tend to form aggregates, which could resist more efficiently to fragmentation and would be unable to be transmitted to daughter cells. The most likely possibility to explain this higher stability could be the longer asparagine stretch present in the prion-forming domain (Supplemental Figure S1 ). Indeed, the prion aggregation properties of the described yeast proteins rely on their content in glutamine and asparagine (Osherovich et al., 2004) . These stretches could stabilize the polymer by specific polar zipper structures and asparagine-ladders (Perutz et al., 2002; Nelson et al., 2005) . Thus, independently of its rate of polymerization, the Ure2p Sp prion aggregates would be less prone to fragmentation than prion aggregates of Ure2p Sc .
In Figure 8 , we have summarized all these observations and integrated then in the analytical model proposed by Tanaka et al. (2006) . Our results suggest that there would be another threshold above which stable prion propagation would not be possible. In this area on the diagram (top left area), the prion particles would be too large and/or to few to allow efficient propagation at cell division. Thus, although in the Tanaka model increasing fiber growth rate favors prion stability, it might be that above a given value, the polymerization rate can become detrimental to prion maintenance.
Together, our results suggest that the concentration of a prion protein modifies a fundamental parameter (the amyloid polymerization rate), which contributes to determine its transmission ability. It is possible that variation in prion protein expression could also interfere with prion propagation in mammals. Prion accumulation occurs in specific neuronal target areas. The reasons that define this cellular tropism are still largely unknown. Interestingly, it was reported that the level of prion protein differs markedly between different neuronal types (Ford et al., 2002) . It would be interesting to study whether the concentration of cellular PrP could contribute to the determination of the variable cellular tropism of prion accumulation. Sp is represented at a position in the diagram reflecting a higher aggregation rate and a lower fragmentation ability as Ure2p Sc . An increase in the Ure2p level leads to an increase in fiber growth rate and the size of prion aggregates, the arrows represent this variation. Our addition to the model defines another threshold (white line) in addition to the threshold defined by Tanaka et al. (2006) (black line). Above of this limit, stable prion propagation is not possible. So, a change of Ure2p Sp level would transform a prion amyloid into a nonprion amyloid.
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